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OBJECTIVES This retrospective review of organ donor records was designed to evaluate the practice of
donor angiography in one organ procurement organization and determine the outcomes of
angiography and its impact on the timing of the organ donation process.
BACKGROUND Concerns about transmission of atherosclerosis from donor to recipient have been heightened
by the increasing prevalence of older donors. Guidelines that advocate the use of angiography
in specific settings have been published, but no formal large-scale review has been performed.
METHODS For the period January 1993 through June 1997, we reviewed all New England Organ Bank
records of donors between the ages of 40 and 65 including any from whom at least one solid
organ was procured. Data abstracted included the presence of risk factors, timing of the
evaluation process and angiographic findings.
RESULTS Coronary angiography was performed in 119 donors aged 40 and older; 64.7% of these hearts
were transplanted. Thirty-eight hearts were transplanted from donors not subjected to
angiography and outcomes were poorer compared with donors who underwent angiography.
Advanced donor age was the only significant predictor of coronary artery disease. The
duration of the procurement process was not prolonged by the performance of angiography.
CONCLUSIONS Donor coronary angiography does not complicate the donation process. Older donor age is
the most powerful predictor of coronary artery disease and may explain prior observations of
poorer outcome with older donor hearts. These factors should be considered when
angiography is performed as part of the heart donor evaluation. (J Am Coll Cardiol 2001;37:
1252–8) © 2001 by the American College of Cardiology
“It makes little sense to replace one diseased heart with
another.”
—DePasquale and Burch, Am Heart J 1969;77:719.
The success of heart transplantation (1) and the widening
gap between the number of patients waiting and the number
of hearts available for transplantation (2) have focused
attention on the need for an expanded supply of donor
hearts. In addition, the demographic profile of potential
donors has changed over the past decade (3,4), with an
increasing proportion of donors dying from nontraumatic
causes. These donors tend to be older than those who die in
motor vehicular and other traumatic accidents. Although
even young donors can have occult coronary atherosclerosis
(5), concern about transmission of atherosclerosis from
donor to recipient is heightened with increasing donor age
(6–8).
Some (1,9–15), but not all (6,16–20), studies have
suggested that advanced donor age is a risk factor for
posttransplant atherosclerosis and/or poorer posttransplant
outcome. Thus, the standard evaluation of the potential
cardiac donor— cardiac history, electrocardiogram and
echocardiogram—is focused, to a great extent, on determin-
ing whether significant coronary disease is likely to be
present (10,21). The evaluation process can be made more
challenging by the presence of (often transient) abnormal-
ities on donor electrocardiograms and echocardiograms that
may occur secondary to the effects of brain death but mimic
findings associated with acute or chronic ischemic heart
disease (22).
In an effort to minimize the risk of transmitting athero-
sclerosis, potential donors sometimes undergo coronary
angiography if a catheterization laboratory and personnel
are available. Several groups have advocated the use of
angiography in older donors (10,23). A task force of the
American College of Cardiology (24) recommended coro-
nary arteriography for male donors over the age of 45 and
for female donors over the age of 50. It was also suggested
that this age threshold be lowered by 5 to 10 years in the
presence of cardiac risk factors. Despite these recommen-
dations, there is considerable uncertainty about the role for
angiography in potential cardiac donors. To help resolve
this uncertainty, we analyzed the experience of the New
England Organ Bank, the organ procurement organization
for much of the New England area (25). Beginning in
January 1993, the adult heart transplant programs in New
England worked in collaboration with the organ bank to
request coronary angiography in donors felt to be at risk for
significant coronary artery disease (CAD).
The goal of this study was to describe and evaluate the
actual experience with angiography of potential donors in
one organ procurement organization. Specifically, we aimed
to: 1) describe the characteristics of the donors undergoing
angiography; 2) describe the results of angiography, the
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predictors of finding coronary disease and the predictors of
performing angiography; 3) assess the impact of angiogra-
phy on the duration of the donor evaluation process; 4)
compare current practice with the recommendations of the
published guideline and determine whether logistics with,
or availability of, angiography limited its use; and 5)
determine whether performing angiography impacts early
posttransplant survival.
METHODS
Eligibility criteria. Subjects were potential heart donors
evaluated by the New England Organ Bank between Janu-
ary 1, 1993, and June 30, 1997. The service area encom-
passed Maine, New Hampshire, Rhode Island, most of
Massachusetts and Vermont and a large section of Con-
necticut, with a total population of approximately 11.1
million people. During the study period, there were five
heart transplant programs (four adult and one pediatric)
averaging 79 transplants per year. Donor hearts imported
into the region were not considered in this analysis.
We restricted the review to donors aged 40 to 65 years
inclusive who donated at least one solid organ (kidney, liver,
pancreas, lung and/or heart). This age range was used in
order to include donors who would be considered angiog-
raphy candidates according to the American College of
Cardiology (ACC) Guideline. Potential organ donors who
were evaluated but not used were not considered in this
analysis. The donors were assigned to four subgroups
according to whether an angiogram was obtained (angiog-
raphy performed 5 YA; angiography not performed 5 NA)
and whether the heart was procured and transplanted (heart
transplanted 5 YH; heart not transplanted 5 NH) as
follows: 1) donors who had coronary angiography per-
formed as part of the donor evaluation and whose hearts
were transplanted (YA/YH); 2) donors who had coronary
angiography performed but whose hearts were not subse-
quently transplanted (YA/NH); 3) donors who did not
undergo angiography and whose hearts were not trans-
planted (NA/NH); and 4) donors who were not subjected to
angiography but whose hearts were transplanted (NA/YH).
A potential heart donor was classified as lacking consent
if there were either family refusal to provide consent or a
formal determination at the time of donor evaluation by the
transplant coordinator and medical director of the New
England Organ Bank that heart donation was not medically
or logistically feasible (in which case, consent was not
requested).
In addition, we abstracted the charts from 15 donors ,40
years of age who had an angiogram performed in order to
summarize the entire experience with angiography regard-
less of donor age.
Permission to review the charts of the above patients was
granted by the Medical Oversight Board of the New
England Organ Bank.
Data from medical records of potential donors. All donor
charts were reviewed for information in several areas:
clinical characteristics and medical history; time of brain
death declaration, angiography (if performed) and aortic
cross-clamp; results of laboratory and noninvasive evalua-
tion (including electrocardiogram and echocardiogram);
medications used during donor management; cause of donor
death and the stated reason (if any) for donor unsuitability.
Hypertension in the donor was defined as a history of, or
treatment for, high blood pressure for at least one year
preceding brain death. Diabetes was defined as hyperglyce-
mia requiring treatment with oral hypoglycemic agents or
insulin prior to the terminal admission. A history of past or
ongoing nicotine abuse qualified the donor as a cigarette
smoker. In most cases, we did not have information about
the presence or absence of a family history of CAD.
Cardiopulmonary resuscitation (CPR) was recorded if chest
compressions were required during the initial phase of care
or during subsequent donor management. Arrhythmias
detected during donor management were classified and
coded as either supraventricular or ventricular. Use of a
vasopressor or inotrope was defined as the infusion of an
intravenous agent other than low dose dopamine (,5
mg/kg/min) to support donor blood pressure or cardiac
output. Cause of donor death was classified as either from
central nervous system causes (cerebrovascular accident,
intracranial hemorrhage of any type or primary brain tu-
mor), traumatic brain injury or miscellaneous (asphyxiation,
poisoning, other).
With regard to the results of coronary angiography,
obstructive CAD was deemed to be present if at least one
main artery or branch was reported to have a $50% stenosis;
nonobstructive disease was present if all lesions were ,50%.
A qualitative report of “significant,” or “moderate” or greater
disease severity was coded as obstructive CAD.
Duration of the evaluation process was obtained from
transplant coordinator records detailing the time from brain
death declaration to angiography and to aortic cross-clamp
during cardiectomy.
Availability of cardiac catheterization facilities. All do-
nor hospitals were contacted to confirm the presence or
absence of catheterization facilities during the study period.
Recipient survival. Evaluation of survival was limited to
the recipients transplanted at programs within the region of
the New England Organ Bank. The outcomes of donor
hearts exported to transplant centers outside the region were
not included. Cause of death was provided by each partic-
Abbreviations and Acronyms
ACC 5 American College of Cardiology
CAD 5 coronary artery disease
CI 5 confidence interval
CPR 5 cardiopulmonary resuscitation
NA 5 donor angiography not performed
NH 5 donor heart not transplanted
YA 5 donor angiography performed
YH 5 donor heart transplanted
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ipating transplant program according to standard definitions
used by the United Network for Organ Sharing.
Statistical analysis. Descriptive statistics were first calcu-
lated for the four donor groups. The chi-square and Fisher
exact tests were used to determine whether significant
associations existed between the donor subgroups for se-
lected donor characteristics. Analysis of variance was used to
detect differences in age between the donor groups. The
Cochran-Armitrage trend test for linear proportions was
calculated to detect time trends in the utilization of angiog-
raphy and in the rate of procurement of hearts in donors
undergoing angiography. Second, logistic regression models
were developed to measure the relation of selected factors
with the presence of CAD and with the decision to perform
angiography. Deviance and Person residuals, and the
Hosmer-Lemeshow statistic, were all examined to assess
adequacy of model fit. Third, analysis of variance and t tests
were utilized to detect differences between elapsed time
comparisons and donor group; Tukey’s studentized range
test was employed to isolate differences resulting in the
analysis of variance. Fourth, survival analysis of recipients of
hearts from donors who did and did not have angiography
was performed using the Kaplan-Meier method and the
Wilcoxon test. Differences in cause of death between groups
were analyzed with the Fisher exact test. All analyses were
executed with SAS software (Release 6.12, SAS Institute,
Cary, North Carolina). Statistical significance was defined
as p , 0.05.
RESULTS
Descriptive characteristics of potential donors. There
were 364 potential heart donors between the ages of 40 and
65 inclusive during the 4.5-year interval under study (Fig.
1). The medical record for one non-heart-beating donor
was not abstracted. Of the remaining 363 donors, 119
underwent coronary angiography; results were available for
118. Seventy-seven hearts (or 64.7%) were subsequently
procured and transplanted (YA/YH); 42 were not procured
(YA/NH). Hearts were transplanted without angiography
from 38 donors (NA/YH). Of the remaining 206 donors,
consent for heart donation was not obtained in 67; none of
the remaining 139 underwent angiography, nor were their
hearts transplanted (NA/NH).
Excluding the group without consent, the donors in this
series were evaluated at 74 different hospitals (range 1 to 24
donors per hospital). Fifty-four of these hospitals had
angiographic facilities at the time of donor evaluation. The
percentage of donors at hospitals with catheterization facil-
ities was 88.8%.
Baseline characteristics of the donors are shown in Table
1. There were significant differences in age, performance of
CPR and smoking history but not cause of death or other
cardiac risk factors.
The use of angiography in donors 40 years of age and
older increased over the study period when analyzed as a
percentage of donors (1993, 30.0%; 1994, 36.1%; 1995,
40.9%; 1996, 48.5%; 1997, 46.3%; p 5 0.024). However,
among those donors who were studied by angiography, the
percentage whose hearts were procured did not increase
significantly (1993, 61.1%; 1994, 63.6%; 1995, 66.7%; 1996,
63.6%; 1997, 68.4%; p 5 NS).
Findings on donor angiography. More donors were found
to have CAD of any severity in the YA/NH group (28/42,
66.7%) compared with the YA/YH group (22/76, 28.9%).
Obstructive disease, defined by a finding of a lesion $50%
Figure 1. Schema outlining the distribution of the 367 donors between the
ages of 40 and 65 inclusive during the study period of January 1993 to June
1997. At least one solid organ was procured from each donor.
Table 1. Donor Characteristics
NA/NH
(n 5 139)
YA/NH
(n 5 42)
YA/YH
(n 5 77)
NA/YH
(n 5 38)
p
Value
Age, in years (6 SD) 50.6 6 6.7 50.8 6 5.7 47.6 6 5.5 44.8 6 3.7 0.001
Male (%) 72 (51.8%) 26 (61.9%) 47 (61.0%) 16 (42.1%) NS
Hypertension [# unknown] 55 (40.4%) [3] 15 (36.6%) [1] 29 (38.7%) [2] 10 (26.3%) NS
Diabetes [# unknown] 6 (4.3%) [1] 2 (4.9%) [1] 5 (6.5%) 0 (0.0%) NS
CPR [# unknown] 28 (20.4%) [2] 2 (4.8%) 7 (9.1%) 4 (11.1%) [2] 0.027
Cigarettes [# unknown] 99 (72.8%) [3] 36 (87.8%) [1] 56 (73.7%) [1] 18 (47.4%) 0.001
Arrhythmia 5 (3.6%) 1 (2.4%) 9 (11.7%) 3 (7.9%) NS
Cause of death: CNS 95 (68.3%) 31 (73.8%) 59 (76.6%) 26 (68.4%) NS
Cause of death: head trauma 24 (17.3%) 8 (19.0%) 14 (18.2%) 6 (15.8%) NS
Vasopressor and/or inotrope 70 (50.4%) 22 (52.4%) 40 (51.9%) 13 (34.2%) NS
CNS 5 central nervous system; CPR 5 cardiopulmonary resuscitation; NA/NH 5 donor angiography not performed, heart not
transplanted; NA/YH 5 donor angiography not performed, heart transplanted; NS 5 not significant; YA/NH 5 donor
angiography performed, heart not transplanted; YA/YH 5 donor angiography performed, heart transplanted.
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in a main coronary artery, was present in 33.3% (n 5 14)
and 0% of donors in the two groups, respectively. Among
the donors in the YA/NH group who did not have obstruc-
tive CAD, six had nonobstructive CAD in two or more
vessels; two had coronary artery spasm in the absence of
obstructive disease; and one had multiple coronary arterio-
venous fistulae. Other reasons for unsuitability of YA/NH
donors included abnormal wall motion on ventriculography
(n 5 11), abnormalities noted on open visual inspection in
the operating room (n 5 5), abnormal hepatitis serology
(n 5 1) and progressive hemodynamic instability (n 5 1).
We could not determine the reason in one donor.
A small coronary-to-pulmonary artery fistula was noted
in one donor on angiography; this heart was transplanted.
Four hearts from potential donors who did not undergo
angiography were rejected intraoperatively on the basis of
surgical palpation of the coronary arteries.
No vascular or other complications of angiography were
recorded during the subsequent final stages of the procure-
ment process.
Predictors of finding donor CAD. The sole predictor of
finding obstructive or nonobstructive CAD in donors un-
dergoing angiography was increasing donor age. Using a
donor age of 40 to 44 years as the reference group, the odds
ratio for finding disease in donors aged 45 to 49 years was
4.22 (95% confidence interval [CI] of 1.35 to 13.2). For
donors aged 50 years and older, the corresponding odds
ratio (OR) was 4.01 (CI 1.35–11.95). Histories of smoking
(OR 2.47, CI 0.86 to 7.09), donor gender (OR 1.99, CI
0.86 to 4.63) and hypertension (OR 1.51, CI 0.66 to 3.45)
were also in the model but did not reach statistical signifi-
cance.
Predictors of performing angiography. Potential factors
influencing the decision to proceed with angiography in
donors 40 years of age and older are a history of cigarette
smoking or hypertension and increasing donor age. Con-
versely, the need for CPR during donor evaluation and
management may be a marker for an unstable donor and
hence procurement without angiography. By logistic regres-
sion, limiting the analysis to donors at hospitals with
angiography facilities, only CPR (OR 0.39; 95%CI 0.16–
0.94, p 5 0.037) was a statistically important factor (i.e.,
donors who underwent CPR were less likely to have an
angiogram performed).
Duration of the evaluation and procurement process.
Elapsed times from brain death declaration to angiography
and from brain death declaration to aortic cross-clamp
during procurement are shown in Table 2. The times were
shortest for the NA/NH group, reflecting, at least in part,
the 7.2% (10/139) of donors in this category who were
rushed to the operating room because of hemodynamic
instability. The other groups showed no overall difference in
the total time, suggesting that angiography did not delay the
procurement process. However, in one case, the family of a
potential donor with cardiac risk factors completely with-
drew consent after they expressed concern that the angiog-
raphy would prolong the process of organ procurement.
Actual practice compared with published guidelines and
reasons for unsuitability of donor hearts. The number of
donors meeting ACC Guideline indication for angiography
in the YA/NH group was 37 (or 88.1% of the total). The
corresponding number in the YA/YH group was 66 (or
85.7%).
A significant proportion (118 of 139, or 84.9%) of donors
in the NA/NH group would have met ACC criteria.
Among this group of donors, the number of males $45
years of age and females $50 with no history of hyperten-
sion, smoking or diabetes was 13. The number of males
$40 and females $45 with one or more of those risk factors
was 105 (63 with one risk factor, 42 with two risk factors).
The number of NA/NH donors who were in noncatheter-
ization facilities was 24 of 139 (or 19 of the 118 meeting
criteria for angiography), but lack of availability of cathe-
terization or logistics was cited in organ bank records in only
12 cases. Echocardiographic findings, mostly abnormal wall
motion, were cited in 36 cases and served as the only reason
for excluding the potential heart donor in 26. Age was listed
as the only reason for nonutilization in 14. Among the other
reasons for nonutilization of donor hearts, medical comor-
bidities such as chronic renal failure were cited in 16 cases,
hemodynamic instability in 10, medical examiner limita-
tions in seven, ventricular or atrial arrhythmias in five,
serology in four, social history in four, poor oxygenation in
three, prolonged CPR in three, use of high dose vasopres-
sors in two, and lack of an appropriate recipient or revoca-
tion of consent in one each. Documented or suspected
myocardial infarction on presentation or a history of CAD
was listed in 26 prospective donors.
Of note, 21 of the 38 (55.3%) donors in the NA/YH
group were actually in hospitals with the capability to
perform cardiac catheterization, but no study was per-
formed.
Outcome following transplantation. Graft survival was
lower for the select group of donors $40 years of age who
Table 2. Duration of the Procurement Process by Donor Group, in Minutes
Time Frame NA/NH YA/NH YA/YH NA/YH
BD–Angio [# unknown] na 516 6 350 [10] 441 6 228 [21] na
Angio–XC [# unknown] na 477 6 174 [9] 551 6 192 [19] na
BD–XC [# unknown] 773 6 334 [2] 993 6 367 [1] 1007 6 235 [3] 946 6 285 [1]
BD–Angio 5 time elapsed from brain death declaration to angiography, in minutes; Angio–XC 5 time elapsed from
angiography to aortic cross-clamp, in minutes; BD–XC 5 total time elapsed from brain death declaration to aortic cross-clamp,
in minutes; na 5 not applicable; NA 5 donor angiography not performed; NH 5 donor heart not transplanted; YA 5 donor
angiography performed; YH 5 donor heart transplanted.
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were not subjected to angiography, compared with donors
who underwent angiography (Fig. 2) (Wilcoxon test, p 5
0.017). This difference is attributable to early graft failure,
which was more common among recipients of hearts from
donors who did not undergo angiography (7/35 or 20%)
versus those who did (3/70, 4%, p 5 0.015). There were no
other differences in the cause of death (rejection, infection,
graft CAD, malignancy or multisystem organ failure) be-
tween the groups.
Donors under 40 years of age subjected to angiography.
An additional 15 potential donors (10 male) who were ,40
years of age had angiography. Four of these hearts were not
transplanted because of abnormal wall motion (n 5 2),
elevated end-diastolic pressure with mitral regurgitation
(n 5 1) and a finding of diffuse coronary spasm versus
diffuse coronary disease (n 5 1). One of the donors had an
atrial septal defect, which was repaired intra-operatively at
the time of transplant.
DISCUSSION
Angiography of the potential donor has been advocated as
the preferred method to screen donors who carry risk factors
for CAD (10,23,24). In this study using data from the New
England Organ Bank, we found that coronary angiography
was performed in 40.2% (119 of 296) of donors for whom
consent was obtained for heart donation over a period of 4.5
years. The use of angiography has increased over time. If the
donor underwent CPR during management, angiography
was less frequently performed, likely reflecting instability in
the donor. From the 119 potential donors who underwent
angiography, 77 hearts were deemed to be acceptable and
transplanted. Not surprisingly, the strongest predictor of
donor coronary disease was advanced donor age. Donors
aged 45 to 49 years were 4.22 times more likely to have
CAD than donors aged 40 to 44 years. Donors aged 50
years and older had a corresponding odds ratio of 4.01; the
lack of further increase in risk likely represents selection
bias. A history of smoking in the donor was the only other
factor to approach statistical significance and could be an
important factor in a larger sample size.
There were no complications of angiography recorded
and, in contrast to the report by Jacobbi et al. (26), the
procedure did not appear to prolong the procurement
process.
Donor angiography and outcomes. Use of angiography
was not associated with poorer subsequent outcome. In fact,
by Kaplan-Meier analysis, survival of recipients of hearts
from donors greater than or equal to 40 years of age was
lower in the early posttransplant period if the donor was not
subjected to angiography. Early graft failure as a cause of
death was more common in this group, raising the possi-
bility of poorer preservation secondary to undiagnosed
donor coronary disease in these hearts. Therefore, we think
that the published data suggesting a worse outcome for
recipients of older donor hearts may be related to undiag-
nosed pre-existing CAD. Performance of angiography and
the subsequent removal of a potential donor with CAD
from the donor pool may significantly reduce the risk of
death following transplant. Alternatively, some investigators
have advocated the use of coronary artery bypass grafting at
the time of transplant and/or the use of an alternative
recipient list when donor disease is detected (27,28).
Donor angiography and guidelines. The majority of do-
nors undergoing angiography clearly met criteria for the
procedure according to published guidelines. Among donors
who did not undergo angiography, hemodynamic instability
and abnormal wall motion on echocardiography were two
common reasons cited for unsuitability of the donor heart.
Whether or not donors in the latter category should be more
strongly considered for angiography in order to rule out
pre-existing coronary disease as the culprit cannot be deter-
mined from these data. However, if it can be shown that the
abnormal wall motion is not due to CAD, the likelihood is
greater that brain death alone is responsible (22,29). Given
the possibly reversible nature of this abnormality, the supply
of donor hearts could be increased by a more aggressive
evaluation of these potential donors (30).
Alternatives to angiography are limited. Several investi-
gators have suggested that bench angiography (31,32) at the
time of organ recovery can help to determine whether
significant proximal coronary disease is present. However,
the safety and utility of this technique in human heart
transplantation have not been proven.
Appropriate use of donor angiography. Given the aging
of the donor population (3,4), the finding that older donors
have more CAD than younger donors by intravascular
ultrasound (7,8) and our results confirming that CAD is
more likely with increasing age of the donor, we suggest that
a conservative approach (33) toward procurement may be
reasonable if angiography is logistically difficult or if the
donor appears to be hemodynamically unstable.
Figure 2. Kaplan-Meier plot comparing survival posttransplant among
recipients of donors $40 who did (dashed line) or did not (solid line)
undergo angiography before heart procurement. Significant at the p 5
0.017 level. See text for details.
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Conversely, it is also possible that some overuse of
angiography exists. In this study, 57.6% of angiograms
revealed minimal or no CAD (either obstructive or nonob-
structive). However, this percentage is not unreasonably
high in light of the risks associated with the transplantation
a diseased donor heart.
Limitations of the study. We did not assess the financial
impact of angiography on the procurement process. It has
been suggested that, in some instances, the expansion of
donor criteria increases costs (34). During the period under
study, donor hospitals were reimbursed for angiography, but
the charges varied widely from $1,000 to $5,000, and not all
donor hospitals requested payment for this service.
We lacked access to complete hospital records and
adequate information on the status of potential recipients at
the time of donor identification. Hence, it was not possible
to ascertain the exact decision making at the time of organ
procurement. Further, no direct data are available to mea-
sure the extent to which exposure to intravenous radio-
graphic contrast may affect early renal function following
subsequent kidney transplant (35), though avoidance of left
ventriculography during donor catheterization seems rea-
sonable.
The study reflects the experience of one organ procure-
ment organization in one region of the country. Practices
may differ in other parts of the country. It has already been
documented that use and availability of catheterization
facilities vary considerably (36) across the United States.
However, given that the lack of availability of angiography
was cited in only a small minority of cases in this study, it is
unlikely to be a major issue limiting heart procurement in
the United States.
In conclusion, we believe that donor angiography can be
widely applied without complicating or significantly pro-
longing the organ procurement process. Older donors com-
prise the highest risk group for finding CAD. Increased use
of angiography in donors who have abnormal wall motion
on echocardiography may increase yield but further study is
indicated. A systematic approach to invasive donor evalua-
tion encompassing current guidelines and clinical criteria
should be developed in order to optimize the use of donor
angiography, thereby minimizing the loss of potentially
viable donor hearts while decreasing the risk of transmission
of occult CAD.
Acknowledgments
The authors thank Dr. Francis L. Delmonico for his
encouragement and thoughtful review of an earlier version
of the manuscript, and Sui Tsang for help in the analysis of
recipient survival.
Reprint requests and correspondence: Dr. Paul J. Hauptman,
Division of Cardiology, St. Louis University Health Sciences
Center, 3635 Vista Avenue at Grand Boulevard, St. Louis,
Missouri 63110. E-mail: Hauptmpj@slu.edu.
REFERENCES
1. Hosenpud JD, Bennett LE, Keck BM, Fiol B, Boucek MM, Novick
RJ. The Registry of the International Society for Heart and Lung
Transplantation: Seventeenth Official Report—2000. J Heart Lung
Transplant 2000;19:901–3.
2. Randall T. Too few human organs for transplantation, too many in
need . . . and the gap widens. JAMA 1991;265:1223, 1227.
3. Himes L, van Buren C, Young JB, Stanbridge RD, Durand R, Nelson
K. The changing demographics of an organ donor population. J
Transplant Coord 1995;5:87–92.
4. Hauptman PJ, O’Connor K. Procurement and allocation of solid
organs for transplantation. N Engl J Med 1997;336:422–31.
5. McNamara JJ, Molot MA, Stremple JF, et al. Coronary artery disease
in combat casualties in Vietnam. JAMA 1971;216:1185–7.
6. Botas J, Pinto FJ, Chenzbraun A, et al. Influence of preexistent donor
coronary artery disease on the progression of transplant vasculopathy:
an intravascular ultrasound study. Circulation 1995;92:1126–32.
7. Tuzcu EM, Hobbs RE, Rincon G, et al. Occult and frequent
transmission of atherosclerotic coronary disease with cardiac transplan-
tation: insights from intravascular ultrasound. Circulation 1995;91:
1706–13.
8. Gao HZ, Hunt SA, Alderman EL, Liang D, Yeung AC, Schroeder
JS. Relation of donor age and preexisting coronary disease on angiog-
raphy and intracoronary ultrasound to later development of accelerated
allograft coronary artery disease. J Am Coll Cardiol 1997;29:623–9.
9. De Angelis E, Keogh A, Anderson P, et al. Older donors—inferior
survival using donors .55 years. J Heart Lung Transplant 1996;15:
S47.
10. Laske A, Niederhauser U, Carrel T, von Segesser L, Turina M. Are
elderly organ donors acceptable for heart transplantation? Transplant
Proc 1992;24:2679–80.
11. Mercer P, Sharples L, Edmunds J, et al. Evaluating the donor pool:
impact of using hearts from donors over the age of 49 years. Transplant
Proc 1997;29:3293–6.
12. Mehra MR, Ventura HO, Chambers R, et al. Predictive model to
assess risk for cardiac allograft vasculopathy: an intravascular ultra-
sound study. J Am Coll Cardiol 1995;26:1537–44.
13. Busson M, N’Doye P, Benoit G, et al. Donor factors influencing organ
transplant prognosis. Transplant Proc 1995;27:1662–4.
14. Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant
coronary artery disease detected by coronary angiography: a multi-
institutional study of preoperative donor and recipient risk factors.
J Heart Lung Transplant 1998;17:744–53.
15. McGiffin DC, Savunen T, Kirklin JK, et al. Cardiac transplant
coronary artery disease. A multivariable analysis of pretransplantation
risk factors for disease development and morbid events. J Thorac
Cardiovasc Surg 1995;109:1081–8.
16. Drinkwater DC, Laks H, Blitz A, et al. Outcomes of patients
undergoing transplantation with older donor hearts. J Heart Lung
Transplant 1996;15:684–91.
17. Hoercher K, Young JB, Stewart RW, McCarthy PM, Smedira N,
Kendall K. The use of older heart donors may not impact mortality or
morbidity: a single center experience. J Heart Lung Transplant
1997;16:83.
18. Zuckermann A, Kocher A, Simon P, et al. Expanding the donor pool
in cardiac transplantation by accepting donor hearts .40 years.
Transplant Proc 1996;28:179–80.
19. Ibrahim M, Masters RG, Hendry PJ, et al. Determinants of hospital
survival after cardiac transplantation. Ann Thorac Surg 1995;59:
604–8.
20. Schuler S, Matschke K, Loebe M, Hummel M, Fleck E, Hetzer R.
Coronary artery disease in patients with hearts from older donors:
morphologic features and therapeutic implications. J Heart Lung
Transplant 1993;12:100–8.
21. Hauptman PJ, Mudge GH Jr. Evaluation and management of poten-
tial heart donors for transplantation. Cardiol Rev 1998;6:100–6.
22. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A.
Left ventricular wall motion abnormalities in patients with subarach-
noid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol
1994;24:636–40.
23. Baumgartner WA, Reitz BA, Oyer PE, Stinson EB, Shumway NE.
Cardiac homotransplantation. Curr Prob Surg 1979;16:1–61.
1257JACC Vol. 37, No. 5, 2001 Hauptman et al.
April 2001:1252–8 Angiography of Potential Cardiac Donors
24. Baldwin JC, Anderson JL, Boucek MM, et al. Task Force 2: donor
guidelines. J Am Coll Cardiol 1993;22:15–20.
25. Kirkman RL, Milford EL, Luskin RS. The New England Organ
Bank—lessons from running a regional organ bank. In: Terasaki PI,
Cecka JM, eds. Clinical Transplants 1993. Los Angeles, CA: UCLA
Tissue Typing Laboratory, 1993:317–24.
26. Jacobbi LM, McBride V, Like K, Rose D. Increasing the donor pool:
recovery of hearts from older donors. Transplant Proc 1997;29:
3297–8.
27. Laks H, Gates RN, Ardehali A, et al. Orthotopic heart transplantation
and concurrent coronary bypass. J Heart Lung Transplant 1993;12:
810–5.
28. Laks H, Scholl FG, Drinkwater DC, et al. The alternate recipient list
for heart transplantation: does it work? J Heart Lung Transplant
1997;16:735–42.
29. Pollick C, Cujec B, Parker S, Tator C. Left ventricular wall motion
abnormalities in subarachnoid hemorrhage: an echocardiographic
study. J Am Coll Cardiol 1988;12:600–5.
30. Rayburn BK, Burton TM, Wannenburg T, Pennington DG, Oaks
TE. Are efforts at expanding the donor pool misdirected? J Heart
Lung Transplant 1998;17:998–1003.
31. Lee CC, Aruny JE, Laurence RG, Appleyard RF, Couper GS, Cohn
LH. Bench coronary angiography: a potentially useful method to assess
coronary artery disease in the older heart without catheterization
laboratory angiography. J Heart Lung Transplant 1992;11:693–7.
32. Robicsek F, Masters TN, Thomley AM, Rice HE, Morales-Reyna J.
Bench coronary cineangiography: a possible way to increase the
number of hearts available for transplantation. J Thorac Cardiovasc
Surg 1992;103:490–5.
33. Copeland JG. Only optimal donors should be accepted for heart
transplantation: protagonist. J Heart Lung Transplant 1995;14:1038–
42.
34. Jacobbi LM, McBride VA, Etheredge EE, et al. The risks, benefits
and costs of expanding donor criteria. Transplantation 1995;60:
1491–6.
35. Solomon R, Werner C, Mann D, D’Elia J, Silva P. Effects of saline,
mannitol, and furosemide on acute decreases in renal function induced
by radiocontrast agents. N Engl J Med 1994;331:1416–20.
36. Pilote L, Califf RM, Sapp S, et al. Regional variation across the United
States in the management of acute myocardial infarction. N Engl
J Med 1995;333:565–71.
1258 Hauptman et al. JACC Vol. 37, No. 5, 2001
Angiography of Potential Cardiac Donors April 2001:1252–8
